Drucker-Colín R, Dreyfus-Cortés G, Chávez L, Aguilar R, McGinty D, Bowersox S
J Neurosci Res. 1983;9(4):425-35. doi: 10.1002/jnr.490090408.
Neurophysiological and biochemical mechanisms regulating REM sleep episodes were studied in behaving cats with chronic electrodes. Push-pull perfusion of the midbrain or pontine reticular formation (RF) by a protein synthesis inhibitor, chloramphenicol (CAP), reduced neuronal unit discharge, particularly discharge bursts, within the perfused area, and reduced the incidence of sustained REM periods. During transitions to "aborted" as compared to sustained REM episodes. RF unit discharge was reduced, under all conditions. In 72-hour sleep deprived cats, systemic injections of both atropine (ATR) and CAP attenuated REM rebound, but with different patterns. CAP reduced REM episode frequency. ATR reduced REM duration. ATR also reduced PGO wave frequency. Combined CAP and ATR treatment produced additive REM depressant effects. These data suggest that cholinergic mechanisms regulate PGO activity and maintenance of REM episodes and that protein synthesis-dependent mechanisms regulate RF unit discharge bursts, and REM triggering.
利用慢性电极在行为猫身上研究了调节快速眼动(REM)睡眠期的神经生理和生化机制。用蛋白质合成抑制剂氯霉素(CAP)对中脑或脑桥网状结构(RF)进行推挽灌注,可减少灌注区域内的神经元单位放电,尤其是放电爆发,并降低持续REM期的发生率。与持续REM期相比,在向“中止”REM期过渡期间,在所有条件下RF单位放电均减少。在剥夺睡眠72小时的猫中,全身注射阿托品(ATR)和CAP均可减弱REM反弹,但方式不同。CAP降低REM期频率。ATR缩短REM持续时间。ATR还降低PGO波频率。CAP和ATR联合治疗产生相加的REM抑制作用。这些数据表明,胆碱能机制调节PGO活动和REM期的维持,而蛋白质合成依赖性机制调节RF单位放电爆发和REM触发。